Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 234-240, January 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meuillet, E. J.
Right arrow Articles by Bremer, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meuillet, E. J.
Right arrow Articles by Bremer, E. G.
[Cancer Research 59, 234-240, January 1, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

Sialidase Gene Transfection Enhances Epidermal Growth Factor Receptor Activity in an Epidermoid Carcinoma Cell Line, A4311

Emmanuelle J. Meuillet, Roger Kroes, Hirotaka Yamamoto, Thomas G. Warner, Jeffry Ferrari, Barbara Mania-Farnell, David George, Abdelhadi Rebbaa, Joseph R. Moskal and Eric G. Bremer2

The Brain Tumor Research Program, Children’s Memorial Hospital and The Chicago Institute for Neurosurgery and Neuroresearch, Chicago, Illinois 60614 [E. J. M., R. K., H. Y., B. M-F., D. G., H. R., J. R. M., E. G. B.], and Genentech, Inc., South San Francisco, California 94080 [T. G. W., J. F.]

Glycosphingolipids expressed in cancer cells have been implicated in the modulation of tumor cell growth through their interaction with transmembrane signaling molecules such as growth factor receptors. For glycosphingolipids to interact with growth factor receptors, the presence of sialic acid seems to be essential. Stable transfection of a gene encoding a soluble Mr 42,000 sialidase into a human epidermoid carcinoma cell line (A431) provided an approach by which the level of terminal lipid-bound sialic acid on the cell surface could be altered. In the sialidase-positive clones, the level of ganglioside GM3 was diminished, and little change was observed in protein sialylation. Sialidase-transfected cells grew faster than control cells. Sialidase expression did not modify the binding of epidermal growth factor (EGF) to its receptor but enhanced EGF receptor (EGFR) tyrosine autophosphorylation as compared to that of parental cells or cells transfected with the vector (pcDNA3) alone. Moreover, the phosphorylation of the EGFR, as well as other protein substrates, was observed at low EGF concentrations, suggesting an increase in the receptor kinase sensitivity. These data provided evidence that changes in ganglioside expression in cancer cells by appropriate gene transfection can dramatically affect EGFR kinase activity. Hence, the modulation of ganglioside expression may represent an approach to alter tumor cell growth.




This article has been cited by other articles:


Home page
GlycobiologyHome page
H.-J. Choi, T.-W. Chung, S.-J. Kim, S.-Y. Cho, Y.-S. Lee, Y.-C. Lee, J.-H. Ko, and C.-H. Kim
The AP-2{alpha} transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene
Glycobiology, May 1, 2008; 18(5): 395 - 407.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Masson, L. Troncy, D. Ruggiero, N. Wiernsperger, M. Lagarde, and S. E. Bawab
a-Series Gangliosides Mediate the Effects of Advanced Glycation End Products on Pericyte and Mesangial Cell Proliferation: A Common Mediator for Retinal and Renal Microangiopathy?
Diabetes, January 1, 2005; 54(1): 220 - 227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Tringali, N. Papini, P. Fusi, G. Croci, G. Borsani, A. Preti, P. Tortora, G. Tettamanti, B. Venerando, and E. Monti
Properties of Recombinant Human Cytosolic Sialidase HsNEU2: THE ENZYME HYDROLYZES MONOMERICALLY DISPERSED GM1 GANGLIOSIDE MOLECULES
J. Biol. Chem., January 30, 2004; 279(5): 3169 - 3179.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Y. Boateng, T. J. Hartman, N. Ahluwalia, H. Vidula, T. A. Desai, and B. Russell
Inhibition of fibroblast proliferation in cardiac myocyte cultures by surface microtopography
Am J Physiol Cell Physiol, July 1, 2003; 285(1): C171 - C182.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
E. A. Miljan and E. G. Bremer
Regulation of Growth Factor Receptors by Gangliosides
Sci. Signal., November 26, 2002; 2002(160): re15 - re15.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. M. Crespo, A. R. Zurita, and J. L. Daniotti
Effect of Gangliosides on the Distribution of a Glycosylphosphatidylinositol-anchored Protein in Plasma Membrane from Chinese Hamster Ovary-K1 Cells
J. Biol. Chem., November 15, 2002; 277(47): 44731 - 44739.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
F. Alves, U. Borchers, H. Keim, R. Fortte, J. Olschimke, W. F. Vogel, H. Halfter, and L. F. Tietze
Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone
Glycobiology, August 1, 2002; 12(8): 517 - 522.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Ringerike, F. D. Blystad, F. O. Levy, I. H. Madshus, and E. Stang
Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae
J. Cell Sci., March 15, 2002; 115(6): 1331 - 1340.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. A. Miljan, E. J. Meuillet, B. Mania-Farnell, D. George, H. Yamamoto, H.-G. Simon, and E. G. Bremer
Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides
J. Biol. Chem., March 15, 2002; 277(12): 10108 - 10113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Li, Y. Liu, and S. Ladisch
Enhancement of Epidermal Growth Factor Signaling and Activation of Src Kinase by Gangliosides
J. Biol. Chem., November 9, 2001; 276(46): 42782 - 42792.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
X.-Q. Wang, P. Sun, M. O'Gorman, T. Tai, and A. S. Paller
Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppresion of activation
Glycobiology, July 1, 2001; 11(7): 515 - 522.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Takematsu, S. Diaz, A. Stoddart, Y. Zhang, and A. Varki
Lysosomal and Cytosolic Sialic Acid 9-O-Acetylesterase Activities Can Be Encoded by One Gene via Differential Usage of a Signal Peptide-encoding Exon at the N Terminus
J. Biol. Chem., September 3, 1999; 274(36): 25623 - 25631.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Li, J. Manela, Y. Kong, and S. Ladisch
Cellular Gangliosides Promote Growth Factor-induced Proliferation of Fibroblasts
J. Biol. Chem., October 27, 2000; 275(44): 34213 - 34223.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.